Nyxoah (NYXH) Income from Continuing Operations (2021 - 2026)
Nyxoah's (NYXH) quarterly Income from Continuing Operations came in at 18210234.43 in Q1 2026, down 22.23% year-on-year from 23414027.23 in Q1 2025, and down 99.93% quarter-over-quarter from 25286517269.8 in Q4 2025.
Nyxoah (NYXH) Income from Continuing Operations (2021 - 2026) Analysis & Trends
Nyxoah's Income from Continuing Operations history runs 6 years deep, the most recent figure standing at 18210234.43 for Q1 2026.
- On a quarterly basis, Income from Continuing Operations fell 22.23% year-over-year to 18210234.43 in Q1 2026; TTM through Mar 2026 was 25253786209.52, a 282.32% increase from a year earlier, with the FY2025 full-year figure at 105792930.79, down 61.6% from the prior year.
- Income from Continuing Operations fell to 18210234.43 in Q1 2026 per NYXH's latest filing, from 25286517269.8 in the prior quarter.
- Across five years, Income from Continuing Operations topped out at 25286517269.8 in Q4 2025 and bottomed at 13879985652.71 in Q4 2024.
- The 5-year median for Income from Continuing Operations is 6160556.15 (2022), against an average of 15455630.54.
- Across the five-year window, Income from Continuing Operations surged 1567.57% in 2022 and tumbled 175602.68% in 2023, its largest moves.
- Year by year, Income from Continuing Operations stood at 13565208968.99 in 2022, then sank by 191.57% to 12421726249.19 in 2023, then slipped by 11.74% to 13879985652.71 in 2024, then surged by 282.18% to 25286517269.8 in 2025, then tumbled by 99.93% to 18210234.43 in 2026.
- Per Business Quant, the three latest NYXH Income from Continuing Operations figures stand at 18210234.43 (Q1 2026), 25286517269.8 (Q4 2025), and 28244371.01 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 240.00 Mn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 823.20 Mn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | -37.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 239.00 Mn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 398.73 Mn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 147.90 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | -77.90 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 13.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 112.77 Mn |
| 10 | Nyxoah | 56.02 Mn | 103.00 Mn | 4.26 Mn | 18.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18.21 Mn |
| Dec 31, 2025 | 25.29 Bn |
| Sep 30, 2025 | -28.24 Mn |
| Jun 30, 2025 | -22.70 Mn |
| Mar 31, 2025 | 23.41 Mn |
| Dec 31, 2024 | -13.88 Bn |
| Sep 30, 2024 | 18.73 Mn |
| Jun 30, 2024 | -13.18 Mn |
| Mar 31, 2024 | 132.31 Mn |
| Dec 31, 2023 | -12.42 Bn |
| Sep 30, 2023 | 8.29 Mn |
| Jun 30, 2023 | -11.91 Mn |
| Mar 31, 2023 | -12.39 Bn |
| Dec 31, 2022 | 13.57 Bn |
| Sep 30, 2022 | -6.16 Mn |
| Jun 30, 2022 | -5.10 Mn |
| Mar 31, 2022 | -7.05 Mn |
| Dec 31, 2021 | -924.33 Mn |
| Sep 30, 2021 | -10.01 Mn |
| Jun 30, 2021 | 8.12 Mn |